Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

Lyophilized Drugs Market to Showcase CAGR of 7.1% and Hit USD US$ 322.9 Billion by 2027; Rising Number of Procedures to Spur Growth

Global Banking And Finance 1 News

Lyophilized Drugs are presently utilized in pharmaceutical manufacturing, food & beverage industries, and biotechnological and drug research industries. It provides many advantages including the security of the products, increased shelf-life, reduced cost, optimized production, and transportation of medicines. Over the years, regulatory authorities have been increasingly approving lyophilized drugs in the market. These drugs offer various advantages such as enhancing the stability of dry power, removing water content without having to heat the product excessively and processing liquid with ease. Recently, in July 2020, Myland N.V. received regulatory approval from the Drug Controller General of India (DCGI) for its remdesivir Lyophilized Powder for injection 100 mg/vial, indicated for the treatment in COVID-19 patients. Hence, approval of such products can stimulate growth of the lyophilized drugs market.

Click Here To Get Sample Copy 

Another key aspect of this market is that major industry players are focused on different inorganic strategies. These strategies are undertaken, in order to expand market presence and enhance the product portfolio. Recently, in August 2020, Sanofi S.A. acquired Principia Biopharma Inc., a U.S.-based biotech company, for US$ 3.4 billion. Therefore, such strategies can potentially augment growth of the lyophilized drugs market.

Recently, in August 2020, GlaxoSmithKline plc received the U.S. Food and Drug Administration (FDA) approval for BLENREP as a monotherapy treatment for adult patients with relapsed or refractory multiple myeloma.

When it comes to regional impact, developed regions such as North America seem to be gaining significant traction in the lyophilized drugs market. This is due to the fact that there is a major presence of key pharmaceutical companies such as Merck & Co. Inc., Fresenius Kabi, and Amneal Pharmaceutical in the region. On the contrary, Asia Pacific seems to be registering promising signs with key players focusing on expanding their production facility.

The lyophilization process not only provides increased protection to the active ingredient of the medication but also helps in retaining the medicinal properties of the medicine. In addition, it has the potential to minimize contamination of raw materials during processing. These advantages have made it highly popular for pharmaceutical manufacturing, medical device manufacturing, and food and beverage industries. Regardless of numerous advantages, there are certain factors that can pose major challenges in growth of the market. One of the key hurdles is product recalls for lyophilized drugs and packaging types. Hence, such factors can impede growth of the lyophilized drugs market in the near future.

Top Key Players Include In Lyophilized Drugs Market Market: Sanofi S.A, Merck & Co., Inc., Fresenius Kabi USA, LLC., Ciron Drugs & Pharmaceuticals Pvt Ltd., GlaxoSmithKline plc., Mylan NV., Pfizer, Inc., Amneal Pharmaceuticals LLC, Otsuka Holdings Co., Ltd.  (Otsuka Pharmaceutical Co., Ltd.), and BTG Plc.

Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/2930

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]

The post Lyophilized Drugs Market to Showcase CAGR of 7.1% and Hit USD US$ 322.9 Billion by 2027; Rising Number of Procedures to Spur Growth appeared first on Gatorledger.

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post